Authors: Cascinu, S Frontini, L Labianca, R Catalano, V Barni, S Graiff, C Picone, G Farinati, F Zonato, S Pessi, MA Curti, C Catalano, G

Citation: S. Cascinu et al., A combination of a fixed dose rate infusion of gemcitabine associated to abolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD), ANN ONCOL, 11(10), 2000, pp. 1309-1311

Authors: Mosconi, S Cascinu, S Zaniboni, A Catalano, V Giordani, P Beretta, GD Martignoni, G Pancera, G Baldelli, AM Poletti, P Curti, C Labianca, R

Citation: S. Mosconi et al., The value of oxaliplatin in combination with continuous infusion +/- bolus5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: A GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial, TUMORI, 86(6), 2000, pp. 465-469

Authors: Jordani, MC Santos, AC Prado, IMR Uyemura, SA Curti, C

Citation: Mc. Jordani et al., Flufenamic acid as an inducer of mitochondrial permeability transition, MOL C BIOCH, 210(1-2), 2000, pp. 153-158

Authors: Mingatto, FE dos Santos, AC Rodrigues, T Pigoso, AA Uyemura, SA Curti, C

Citation: Fe. Mingatto et al., Effects of nimesulide and its reduced metabolite on mitochondria, BR J PHARM, 131(6), 2000, pp. 1154-1160

Authors: Curti, C Mingatto, FE Polizello, ACM Galastri, LO Uyemura, SA Santos, AC

Citation: C. Curti et al., Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity, MOL C BIOCH, 199(1-2), 1999, pp. 103-109